Al­ny­lam plans to ap­peal Covid-19 vac­cine patent rul­ing in case against Mod­er­na

Al­ny­lam agreed to a fi­nal judg­ment that Mod­er­na did not in­fringe on two of Al­ny­lam’s patents, though the com­pa­ny said Fri­day it plans to ap­peal the rul­ing.

Judge Colm Con­nol­ly of the US Dis­trict Court for the Dis­trict of Delaware is­sued an or­der last week against Al­ny­lam on cer­tain patent claims. The com­pa­ny sued Mod­er­na in 2022, al­leg­ing in two suits that the com­pa­ny’s Covid-19 vac­cine in­fringed on Al­ny­lam patents. It al­so sued Pfiz­er, mak­ing sim­i­lar al­le­ga­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.